NCT01862302View on ClinicalTrials.gov

Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

July 31, 2016

Conditions
Postoperative Confusion
Interventions
DRUG

Haloperidol

1mg the night before and 1mg the morning of surgery; OR Haloperidol 2mg the morning of surgery

DRUG

Placebo

1 dose the night before and 1 dose the morning of surgery; OR 2 doses the morning of surgery

Trial Locations (1)

L8L 2X2

Hamilton General Site, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER

NCT01862302 - Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium | Biotech Hunter | Biotech Hunter